REGISTERED
on 17 Jan 2023
Last Applicant/ Owned by
54, rue La Boétie
Paris
FR
75008
Serial Number
90819626 filed on 09th Jul 2021
Registration Number
6952572 registered on 17th Jan 2023
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ESARI
Pharmaceutical preparations for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondylarthritis, cancer, respiratory diseases, cardiovascular diseases, diabetes, blood disorders and diseases, multiple sclerosis, central nervous system disorders and diseases, and neurological, hematological, and lysosomal storage disorders; vaccines
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondylarthritis, cancer, respiratory diseases, cardiovascular diseases, diabetes, blood disorders and diseases, multiple sclerosis, central nervous system disorders and diseases, and neurological, hematological, and lysosomal storage disorders; vaccines
Mark Details
Serial Number
No 90819626
Mark Type
No Service/Collective Mark
Attorney Docket Number
No SYNB 2107968
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Jan 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Jan 2023 | REGISTERED-PRINCIPAL REGISTER |
| 01st Nov 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 01st Nov 2022 | PUBLISHED FOR OPPOSITION |
| 12th Oct 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 29th Sep 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 29th Sep 2022 | EXAMINER'S AMENDMENT ENTERED |
| 29th Sep 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 29th Sep 2022 | EXAMINERS AMENDMENT E-MAILED |
| 29th Sep 2022 | EXAMINERS AMENDMENT -WRITTEN |